KIR2DL1 and neoplasm: Thus, in patients who survived long periods after the cytoreductive therapy, HLA C2-ligands favored the expansion of KIR2DL1+ CD8+ T cells, which showed a gene expression signature related to efficient tumor immunosurveillance.